Denali Therapeutics Inc. Contracts & Agreements

60 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Registration Rights Agreement between Denali Therapeutics Inc. and Investors (June 3, 2025)
Registration Rights Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2025
Notice and Agreement of Partial Termination of Collaboration and License Agreement between Genzyme Corporation and Denali Therapeutics Inc.
Collaboration Agreements
Denali Therapeutics Inc.
Biotechnology
2025
Notice of Termination of Collaboration Program under Option and Collaboration Agreement between Denali Therapeutics Inc. and Takeda Pharmaceutical Company Limited
Termination Agreements
Denali Therapeutics Inc.
Biotechnology
2025
Denali Therapeutics Inc. Amended and Restated Outside Director Compensation Policy (Effective January 31, 2025)
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2025
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2025
Denali Therapeutics Inc. $400 Million Equity Distribution Agreement with Goldman Sachs & Leerink Partners (2025)
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2025
Side Letter Agreement Regarding Termination of ATV:Abeta Program between Denali Therapeutics Inc. and Biogen MA, Inc.
Termination Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2024
Denali Therapeutics Inc. Form of Pre-Funded Warrant to Purchase Common Stock (2024)
Warrant Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2024
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2024
Denali Therapeutics Inc. Compensation Recovery (Clawback) Policy for Section 16 Officers
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2024
Denali Therapeutics Inc. Insider Trading Policy and Guidelines (as amended March 31, 2023)
Code of Ethics
Denali Therapeutics Inc.
Biotechnology
2024
Denali Therapeutics Inc. Form of Pre-Funded Warrant to Purchase Common Stock (2024)
Warrant Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2024
Denali Therapeutics Inc. Securities Purchase Agreement with Purchasers (February 27, 2024)
Purchase Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2024
Nominating Agreement between Denali Therapeutics Inc. and Baker Brothers Life Sciences, L.P. and 667, L.P.
Investor Rights Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2024
Amendment to LRRK2 Collaboration and License Agreement and Waiver of Right of First Negotiation, Option, and License Agreement between Denali Therapeutics Inc. and Biogen
License Agreements
Denali Therapeutics Inc.
Biotechnology
2023
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2023
Denali Therapeutics Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (October 19, 2022)
Underwriting Agreements
Denali Therapeutics Inc.
Biotechnology
2022
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2022
Denali Therapeutics Inc. Amended and Restated Outside Director Compensation Policy (February 3, 2022)
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2022
Denali Therapeutics Inc. $400 Million Equity Distribution Agreement with Goldman Sachs, SVB Securities, and Cantor Fitzgerald
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2022
Side Letter to License and Collaboration Agreements among Denali Therapeutics, BBB Holding Ltd, and F-star Entities (June 30, 2021)
Modification Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Denali Therapeutics Inc. Amended and Restated Outside Director Compensation Policy (April 16, 2021)
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Denali Therapeutics Inc. Amended and Restated Outside Director Compensation Policy (February 5, 2021)
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Amendment No. 5 to Development and Manufacturing Services Agreement between Lonza Sales AG and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Amendment No. 3 to Development and Manufacturing Services Agreement between Lonza Sales AG, Lonza AG, and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Amendment No. 6 to Development and Manufacturing Services Agreement between Lonza Sales AG, Lonza AG, and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Common Stock Purchase Agreement between Denali Therapeutics Inc. and Biogen MA Inc.
Purchase Agreements
Denali Therapeutics Inc.
Biotechnology
MA
2020
Provisional Collaboration and License Agreement between Denali Therapeutics Inc. and Biogen Entities (August 5, 2020)
Collaboration Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Standstill and Stock Restriction Agreement between Denali Therapeutics Inc. and Biogen MA Inc.
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2020
Definitive LRRK2 Collaboration and License Agreement between Denali Therapeutics Inc. and Biogen Entities (October 4, 2020)
License Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Right of First Negotiation, Option and License Agreement between Denali Therapeutics Inc. and Biogen Entities (October 6, 2020)
License Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Denali Therapeutics Inc. Key Executive Change in Control and Severance Plan (Effective November 10, 2017)
Change of Control Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2020
Denali Therapeutics Inc. Amended and Restated Outside Director Compensation Policy (March 24, 2020)
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – Denali Therapeutics Inc.
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Denali Therapeutics Inc. Common Stock Underwriting Agreement with Goldman Sachs, J.P. Morgan, and Jefferies (January 28, 2020)
Underwriting Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Amendment No. 3 to Development and Manufacturing Services Agreement between Lonza Sales AG and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2018
Amendment No. 4 to Development and Manufacturing Services Agreement between Lonza Sales AG and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2018
First Amendment to Lease (Relocation and Expansion) between HCP Oyster Point III LLC and Denali Therapeutics Inc.
Lease Agreements
Denali Therapeutics Inc.
Biotechnology
2018
Amended and Restated Gamma IP License Agreement between F-star Biotechnology Limited and F-star Gamma Limited (August 24, 2016)
License Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2018
Side Letter Agreement Amending License and Collaboration Terms between F-star Entities and Denali Therapeutics Inc.
Collaboration Agreements
Denali Therapeutics Inc.
Biotechnology
2018
Share Purchase Agreement among Denali Therapeutics Inc., Sellers of F-star Gamma Limited, and Shareholder Representative Services LLC (May 30, 2018)
Purchase Agreements
Denali Therapeutics Inc.
Biotechnology
CO
2018
Amendment No. 2 to Development and Manufacturing Services Agreement between Lonza Sales AG and Denali Therapeutics Inc.
Development Agreements
Denali Therapeutics Inc.
Biotechnology
2018
Option and Collaboration Agreement between Denali Therapeutics Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2018
Common Stock Purchase Agreement between Denali Therapeutics Inc. and Takeda Pharmaceutical Company Limited (January 3, 2018)
Purchase Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2018
Denali Therapeutics Inc. and Takeda Pharmaceutical Co. Standstill and Stock Restriction Agreement (2018)
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2018
Denali Therapeutics Inc. 2017 Employee Stock Purchase Plan
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
Denali Therapeutics Inc. Common Stock Underwriting Agreement with Goldman Sachs, Morgan Stanley, and J.P. Morgan
Underwriting Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Denali Therapeutics Inc. Common Stock Certificate
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Denali Therapeutics Inc. Indemnification Agreement with Director or Officer
Indemnification Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Denali Therapeutics Inc. 2017 Equity Incentive Plan
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Denali Therapeutics Inc. 2017 Employee Stock Purchase Plan
Bonus & Incentive Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
Denali Therapeutics Inc. Investors' Rights Agreement (May 8, 2015)
Investor Rights Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Denali Therapeutics Inc. 2015 Stock Incentive Plan (as Amended Through December 13, 2016)
Bonus & Incentive Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Confirmatory Employment Letter Agreement between Denali Therapeutics Inc. and Ryan Watts, Ph.D.
Employment Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Confirmatory Employment Letter Agreement between Denali Therapeutics Inc. and Alexander Schuth, M.D.
Employment Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Confirmatory Employment Letter Agreement between Denali Therapeutics Inc. and Steve Krognes
Employment Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Confirmatory Employment Letter Agreement between Denali Therapeutics Inc. and Carole Ho, M.D.
Employment Agreements
Denali Therapeutics Inc.
Biotechnology
2017
Lease Agreement between HCP Oyster Point III LLC and Denali Therapeutics Inc. for The Cove at Oyster Point
Lease Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
Exclusive License Agreement between Genentech, Inc. and Denali Therapeutics Inc. (June 17, 2016)
License Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017